The pathogenesis of rheumatoid arthritis

Alivernini, S., Firestein, G. S. and McInnes, I. B. (2022) The pathogenesis of rheumatoid arthritis. Immunity, 55(12), pp. 2255-2270. (doi: 10.1016/j.immuni.2022.11.009) (PMID:36516818)

Full text not currently available from Enlighten.

Abstract

Significant recent progress in understanding rheumatoid arthritis (RA) pathogenesis has led to improved treatment and quality of life. The introduction of targeted-biologic and -synthetic disease modifying anti-rheumatic drugs (DMARDs) has also transformed clinical outcomes. Despite this, RA remains a life-long disease without a cure. Unmet needs include partial response and non-response to treatment in many patients, failure to achieve immune homeostasis or drug free remission, and inability to repair damaged tissues. RA is now recognized as the end of a multi-year prodromal phase in which systemic immune dysregulation, likely beginning in mucosal surfaces, is followed by a symptomatic clinical phase. Inflammation and immune reactivity are primarily localized to the synovium leading to pain and articular damage, but is also associated with a broader series of comorbidities. Here, we review recently described immunologic mechanisms that drive breach of tolerance, chronic synovitis, and remission.

Item Type:Articles
Additional Information:S.A. was supported by linea D1 (R4124500654) (Università Cattolica del Sacro Cuore) and Ricerca Finalizzata Ministero della Salute (GR-2018-12366992).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McInnes, Professor Iain
Authors: Alivernini, S., Firestein, G. S., and McInnes, I. B.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Research Centre:College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Immunobiology
Journal Name:Immunity
Publisher:Elsevier (Cell Press)
ISSN:1074-7613
ISSN (Online):1097-4180

University Staff: Request a correction | Enlighten Editors: Update this record